An official website of the United States government
The .gov means it's official.
The site is secure.
View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/FDA | RIN: 0910-AA49 | Publication ID: Spring 1996 |
| Title: Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution | |
| Abstract: The proposed rule would revise and clarify the regulations under part 207 to reduce the burden on manufacturers, packers, and distributors, and to consolidate and streamline the requirements. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| CFR Citation: 21 CFR 207 | |
| Legal Authority: 21 USC 331 21 USC 351 21 USC 352 21 USC 355 21 USC 356 21 USC 357 21 USC 360 21 USC 371 | |
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Included in the Regulatory Plan: No | |
|
Agency Contact: Howard P. Muller Office of Regulatory Policy Department of Health and Human Services Food and Drug Administration Suite 3037 (HFD-7), Center for Drug Evaluation and Research, WO 51, Room 6234, 10903 New Hampshire Avenue, Silver Spring, MD 20993-0002 Phone:301 796-3601 Fax:301 847-8440 Email: howard.mullerjr@fda.hhs.gov |
|
|
Reginfo.gov
An official website of the U.S. General Services Administration and the Office of Management and Budget
Looking for U.S. government
information and services?
Visit USA.gov